Aprepitant
Drugaprepitant 80 mg is given to all patients before surgery
NCT Number: NCT02597907
The purpose of this study was to compare the antiemetic efficacy of aprepitant plus palonosetron versus aprepitant plus ramosetron in high risk patients undergoing laparoscopic cholecystectomy.
Looking for future studies?
Notify Me18 year–65 year
Female
Interventional
Not applicable
The purpose of this study was to compare the antiemetic efficacy of aprepitant plus palonosetron versus aprepitant plus ramosetron in high risk patients undergoing laparoscopic cholecystectomy.
Study is performed during 24 hours after surgery.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
aprepitant 80 mg is given to all patients before surgery
palonosetron 0.075 mg is given to patients in the aprepitant plus palonosetron group after induction of general anesthesia
ramosetron 0.3 mg is given to patients in the aprepitant plus ramosetron group after induction of general anesthesia
Time frame: 24 hours
The incidence of postoperative nausea and vomiting during 24 hours postoperatively
Looking for future studies?
Notify MeKyungpook National University Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07552701
Acute Cholecystitis, Biliary Tract Diseases
Çorum, Turkey (Türkiye)
View Trial DetailsNCT07153575
Arthritis, Hip Osteoarthritis
Balıkesir, Turkey (Türkiye)
View Trial DetailsNCT07813897
Nausea, Pathologic Processes
Dhaka, Bangladesh
View Trial DetailsNCT05888818
Behavior, Health Behavior
Zonguldak, Kozlu, Turkey (Türkiye)
View Trial Details